European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) ...

Medical Information
Sweden
 

För att kunna förse dig med relevant och meningsfull information behöver vi veta mer om dig.

Välj den kategori som beskriver dig bäst.

Detta innehåll är avsett för vårdpersonal. Vill du fortsätta?

May 15, 2020

European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) to permit use of the product COMIRNATY COVID-19 mRNA Vaccine for active immunisation to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 12 years of age and older. During the initial pandemic stage, COMIRNATY COVID-19 mRNA Vaccine may also be distributed with the packaging with the name Pfizer-BioNTech COVID-19 Vaccine.